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Abstract
Background A syndrome of periodic fever, aphthous stomati-
tis, pharyngitis, and adenitis (PFAPA), as well as immunoglob-
ulin A nephropathy (IgAN), may be caused by autoimmune
reactivity nephropathy.
Case-diagnosis/treatment A 10-year-old boy presented with
periodic fever, exudative tonsillitis, oral aphthous ulcer, and
cervical lymph node inflammation. These conditions had
occurred at intervals of about 2–6 weeks since the age of
3 years. Microscopic hematuria, first detected at age 8 years,
worsened during episodes of PFAPA-related fever; since 10
years of age, the hematuria was accompanied by sustained
proteinuria. Examination of a kidney biopsy specimen led to
a diagnosis of IgAN. In the kidney specimen, fractalkine
immunoreactivity and heavy macrophage infiltration were
prominent. Multi-drug cocktail therapy improved the urinal-
ysis findings, and subsequent tonsillectomy succeeded in
controlling recurrences of PFAPA and IgAN. In a post-
treatment renal biopsy specimen, mesangial proliferation
was decreased, and fractalkine immunoreactivity was
absent.
Conclusion Immunologic reactions against certain antigens
in local mucosa, including tonsils, may be impaired in
PFAPA and IgAN, as evidenced by the suppression of both
diseases in our patient by tonsillectomy. Accordingly, the
concurrence of PFAPA and IgAN in our patient appeared to
be a consequence of shared autoimmune mechanisms and
systemic and local increases in cytokine concentrations,
rather than coincidence.
Introduction
Periodic fever, aphthous stomatitis, pharyngitis, and adenitis
syndrome (PFAPA) is a non-genetic auto-inflammatory disease
presenting in children ≤5 years of age. Although details
of its pathogenesis are unclear, periodic abnormalities
involving the mechanism regulating cytokine secretion
have been suggested [1, 2].
Abnormalities of B and T cells have been proposed as
etiologies of immunoglobulin A (IgA) nephropathy (IgAN).
Increased serum IgA levels and increases in IgA-specific
helper T cells or inflammatory cytokines, such as interleukin
6 (IL-6), have been implicated in the transition from IgM to
IgA secretion in this disease [3, 4]. Additionally, excessive
amounts of poorly galactosylated serum IgA1 appears to be
the trigger for generation of glycan-specific IgG and IgA
autoantibodies, resulting in the formation of circulating IgA
immune complexes, which are considered pivotal to the
development of nephritis [5]. Immune complexes deposited
in the glomerular mesangium could promote both systemic
and local secretion of various inflammatory cytokines and
cell-proliferative hormones that cause a further progression
of nephropathy [4].
In this report, we present a child with PFAPA and concur-
rent IgAN. We know of no previous report of such a case.
Since a disoriented immune response triggered by various
antigenic stimuli andmediated by pro-inflammatory cytokines
has been suspected in both diseases, this patient is of interest
in terms of the pathogenic mechanisms underlying the two
diseases.
Case presentation
Since the age of 3 years, a 10 year-old boy had experienced
repeated episodes of fever at or exceeding 38 °C at intervals
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of 2–6 weeks. In each instance, he was treated with anti-
biotics, but the fever persisted for several days. He was
subsequently diagnosed with PFAPA. Microscopic hematu-
ria first appeared at the age of 8 years, after which gross
hematuria occurred during episodes of fever, decreasing to
microscopic hematuria after the fever resolved. Sustained
proteinuria appeared at the age of 10 years. Kidney biopsy,
performed when the daily urinary protein excretion dis-
charge increased to 1.0 g/day, revealed the presence of
cellular crescents in addition to a diffuse, marked increase
in mesangium (Fig. 1a). An immunofluorescence study of
the specimen demonstrated marked granular deposition of
IgA (Fig. 1b) and complement C3 deposition, primarily in
the mesangium. The patient was diagnosed with IgAN.
Mononuclear cell infiltration was also observed in glomeruli
(Fig. 1c). Immunohistologic staining revealed glomerular
infiltration of numerous CD68-positive macrophages
(Fig. 1d). No amyloid deposition was detected in renal
tissue. Since histologic findings suggested a poor prognosis,
multi-drug cocktail therapy was initiated consisting of ste-
roid, immunosuppressant, anticoagulant, and angiotensin-
converting enzyme inhibitor (enalapril maleate), together
with methylprednisolone pulse therapy. This resulted in the
improvement of the urinalysis findings.
Immunohistologic staining of the pre-treatment renal tissue
sample using anti-human CX3CL1/fractalkine antibody
(R&D System, Minneapolis, MN) demonstrated the presence
of fractalkine in glomeruli and renal tubules (Fig. 1e, f).
Fig. 1 Histologic and
immunohistologic evaluations
of the patient’s kidney tissue.
Mesangial proliferation is
accompanied by crescent
formation (a; PAS stain, ×200),
and immunoglobulin A deposits
are demonstrated in the
mesangium by
immunofluorescence (b; ×400).
Mononuclear cell infiltration is
seen in glomeruli (c; PAS,
×400), which is supported by
immunohistologic staining
(d; ×400). Fractalkine is
demonstrated in the glomeruli
(e; ×400) and tubular
epithelium (f; ×200)
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Based on the results of the blood tests run at the onset of
nephropathy, blood urea nitrogen was 18 mg/dL, serum
creatinine was 0.58 mg/dL, and creatinine clearance was
85.5 ml/min/1.48 m2, indicating intact renal function. Serum
IgA was 275 mg/dL. During episodes of fever, increases in
IL-6 (38.2 pg/mL; normal ≤4.0 pg/mL), IL-1β (24.3 pg/mL;
normal ≤10 pg/mL), soluble IL-2 receptor (sIL-2) (1,240 U/
mL; normal ≤500 U/mL), interferon-γ (IFN-γ; 6.3 pg/mL;
normal ≤0.1 pg/mL), and soluble tumor necrosis factor
(TNF) receptor-1 (2,140 pg/mL; normal ≤750 pg/mL) were
observed in addition to increases in procalcitonin, erythro-
cyte sedimentation rate, and the white blood cell count.
During intervals of alleviation of fever, IL-6 (8.7 pg/mL),
IL-1β (18.5 pg/mL), and sIL-2R (784 U/mL) levels
decreased; however, smaller increases persisted between
episodes. Serum concentrations of various immunoglobu-
lins, such as IgG and IgD, and of complement compo-
nents were all normal. Peripheral blood CD4+/CD25+
lymphocytes, which are reported to decrease in PFAPA,
were reduced to 4.6 % (normal range 6–21 %). No
mutation was detected in MEFV, a gene responsible for
familial Mediterranean fever (FMF).
Tonsillectomy was performed 3 months after the cocktail
therapy had been discontinued, followed by discontinuation
of steroids and immunosuppressants. Both hematuria and
proteinuria have subsequently remained absent for 1 year,
and complete remission has been maintained. No fever or
other symptom of PFAPA has occurred. On the other hand,
peripheral blood CD4+/CD25+ lymphocytes remain low,
although they have increased slightly to 5.5 %. In a
follow-up kidney specimen obtained 1 year and 6 months
after the onset of nephropathy, mesangial proliferation was
decreased. Fractalkine could not be detected in either
glomeruli or tubules.
Discussion
While the exogenous or endogenous antigen(s) causing
PFAPA remain unidentified, a decrease in CD4+/CD25+
lymphocytes, which maintain peripheral tolerance to the
immune response and regulate natural immune responses
to prevent autoimmunity, has been reported [6]. Because of
consequent abnormal control of an immune response to
antigenic stimulation, the levels of pro-inflammatory cyto-
kines, such as IL-6, IFN-γ, and IL-1β, increase markedly
during episodes of fever, with smaller increases persisting
between episodes [7], as was observed in our patient. In
PFAPA syndrome, expression of complement-related genes,
such as C1QB and IL-1-related genes, and genes induced by
IFN-γ also increase during episodes of fever [6]. Serum
concentrations of T cell-derived chemokine proteins also
increase in relation to febrile responses [6].
Fractalkine is produced in a form anchored to mem-
branes, while other chemokines are in secretory form. The
expression of this cytokine is enhanced by exposure to
inflammatory cytokines, such as IL-1 and IFN-γ, not only
in dendritic cells and nerve cells but also in renal mesangial
cells and the tubular epithelium. Interaction between
membrane-anchored fractalkine and fractalkine receptors
(CX3CR1), which unlike other cytokines require no medi-
ation by adhesive factors such as integrin, induces adhesion
of inflammatory cells to tissues [8]. Some T cells and macro-
phages that infiltrate the inflammatory focus possess
CX3CR1 and bind with fractalkine [8, 9]. In our study, we
demonstrate intense fractalkine expression in the patient‘s
glomeruli and tubular epithelium, where fractalkine may
promote regional accumulation of inflammatory cells in
the kidney. A recent study by Cox et al. has also demon-
strated an involvement of the CX3CR1-fractalkine axis in
the exacerbation of gross hematuria in patients with IgAN
[10]. In addition, as a result of regional increases in the
concentrations of inflammatory cytokines derived from
these cells in the kidney, mesangial cell proliferation and
crescent formation may be promoted, causing exacerbation
of the disease. In our patient, fractalkine staining disap-
peared after treatment by drugs, including steroids and
immunosuppressants.
Upon exposure to exogenous or endogenous antigens,
circulating immune complexes containing IgA are formed;
IgAN may be triggered when these are deposited in the
kidney [11]. In the tonsils of IgAN patients, CD4+/CD25+
cells have been reported to be reduced, as in patients with
PFAPA; local abnormalities of autoimmunity in the tonsils
have also been suggested [12]. Accordingly, in our patient,
we suspected that the control of immunity was disrupted by
a decrease in CD4+/CD25+ cells, thereby allowing immune
complexes containing IgA to be produced in excess and
deposited in the kidney, with increased cytokine concentra-
tions reflecting the infiltration of inflammatory cells into the
kidney induced by fractalkine. PFAPA-associated hypercy-
tokinemia also presumably contributed to the progression of
nephropathy in our patient. Interestingly, FMF can be asso-
ciated with IgAN, and the involvement of inflammatory
cytokines in the onset and progression both of these diseases
has been suggested [12]. While subsequent systemic immu-
nologic mechanisms leading to the development of PFAPA
and IgAN are different [5, 6], impairment of the initial
immunologic tolerance against various antigens in local
mucosa, including the tonsils, may be a common element
of both diseases, considering that tonsillectomy is an effec-
tive treatment for not only IgAN [13] but also PFAPA [14],
as was also the case in our patient . FMF is associated with
an exaggerated response to streptococcal antigens [15].
PFAPA similarly may include an inappropriate response to
certain antigens impinging upon the tonsils, ultimately
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leading to a worsening of our patient’s urinary findings.
Treatment of our patient with multi-drug cocktail therapy
followed by tonsillectomy achieved satisfactory results in
terms of treating both diseases. We therefore suspect that the
concurrence of PFAPA and IgAN in our patient was not
coincidental but rather a consequence of shared autoimmune
mechanisms and systemic and local increases in cytokine
concentrations.
Abnormal urinary findings, such as hematuria, have been
reported in PFAPA, but not described in detail. To our
knowledge, our report is the first to describe the concurrence
of PFAPA and IgAN in a patient.
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